| Primary |
| Product Used For Unknown Indication |
28.9% |
| Schizophrenia |
18.2% |
| Drug Use For Unknown Indication |
10.5% |
| Psychotic Disorder |
9.3% |
| Bipolar Disorder |
4.8% |
| Schizophrenia, Paranoid Type |
4.4% |
| Depression |
3.8% |
| Schizoaffective Disorder |
3.0% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Anxiety |
1.9% |
| Agitation |
1.7% |
| Ill-defined Disorder |
1.5% |
| Aggression |
1.5% |
| Abnormal Behaviour |
1.4% |
| Bipolar I Disorder |
1.4% |
| Obsessive-compulsive Disorder |
1.3% |
| Parkinson's Disease |
1.2% |
| Autism |
1.1% |
| Suicide Attempt |
1.1% |
| Major Depression |
1.0% |
|
| Weight Increased |
13.4% |
| Tremor |
8.3% |
| Neuroleptic Malignant Syndrome |
6.4% |
| Treatment Noncompliance |
6.1% |
| Psychotic Disorder |
5.4% |
| Death |
4.9% |
| Neutropenia |
4.7% |
| Suicidal Ideation |
4.7% |
| Vomiting |
4.6% |
| Weight Decreased |
4.3% |
| Hyperprolactinaemia |
4.2% |
| Completed Suicide |
4.1% |
| Tardive Dyskinesia |
4.1% |
| Drug Interaction |
3.8% |
| Product Substitution Issue |
3.8% |
| Condition Aggravated |
3.5% |
| Rhabdomyolysis |
3.5% |
| Drug Ineffective |
3.4% |
| Extrapyramidal Disorder |
3.4% |
| Somnolence |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
15.7% |
| Irritability |
13.2% |
| Autism Spectrum Disorder |
13.1% |
| Schizophrenia |
11.3% |
| Drug Use For Unknown Indication |
7.6% |
| Psychotic Disorder |
4.7% |
| Bipolar Disorder |
4.7% |
| Depression |
4.5% |
| Schizophrenia, Paranoid Type |
3.1% |
| Abnormal Behaviour |
3.0% |
| Post-traumatic Stress Disorder |
2.6% |
| Schizoaffective Disorder |
2.4% |
| Anxiety |
2.3% |
| Craniocerebral Injury |
2.2% |
| Relaxation Therapy |
2.2% |
| Insomnia |
2.0% |
| Anaesthesia Procedure |
1.4% |
| Ill-defined Disorder |
1.4% |
| Obsessive-compulsive Disorder |
1.3% |
| Agitation |
1.3% |
|
| Weight Increased |
12.2% |
| Treatment Noncompliance |
9.7% |
| Completed Suicide |
7.9% |
| Tremor |
6.4% |
| Suicide Attempt |
5.5% |
| Weight Decreased |
5.4% |
| Somnolence |
5.0% |
| Neuroleptic Malignant Syndrome |
5.0% |
| Inguinal Hernia |
4.5% |
| Psychotic Disorder |
4.4% |
| Serotonin Syndrome |
4.1% |
| Sydenham's Chorea |
4.0% |
| Vomiting |
3.6% |
| Death |
3.4% |
| Tardive Dyskinesia |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Rhabdomyolysis |
3.3% |
| Respiratory Arrest |
3.1% |
| Overdose |
2.9% |
| Extrapyramidal Disorder |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.6% |
| Schizophrenia |
14.3% |
| Drug Use For Unknown Indication |
13.6% |
| Depression |
9.5% |
| Bipolar Disorder |
5.7% |
| Hypertension |
4.4% |
| Anxiety |
3.9% |
| Schizophrenia, Paranoid Type |
3.5% |
| Psychotic Disorder |
3.4% |
| Pain |
2.6% |
| Insomnia |
2.6% |
| Schizoaffective Disorder |
2.2% |
| Attention Deficit/hyperactivity Disorder |
2.1% |
| Obsessive-compulsive Disorder |
2.0% |
| Dementia Alzheimer's Type |
1.9% |
| Epilepsy |
1.7% |
| Abnormal Behaviour |
1.5% |
| Hiv Infection |
1.5% |
| Sleep Disorder |
1.5% |
| Diabetes Mellitus |
1.4% |
|
| Weight Increased |
13.3% |
| Vomiting |
9.8% |
| Psychotic Disorder |
7.9% |
| Weight Decreased |
7.5% |
| Somnolence |
5.1% |
| Suicidal Ideation |
5.0% |
| White Blood Cell Count Increased |
4.9% |
| Death |
4.1% |
| Granulocytopenia |
4.0% |
| Suicide Attempt |
4.0% |
| Tremor |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Type 2 Diabetes Mellitus |
3.8% |
| Pyrexia |
3.7% |
| Pancreatitis |
3.6% |
| Syncope |
3.3% |
| Urinary Tract Infection |
3.2% |
| Tachycardia |
3.1% |
| Tic |
2.8% |
| Schizophrenia |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
20.6% |
| Drug Use For Unknown Indication |
15.0% |
| Depression |
7.5% |
| Psychotic Disorder |
7.4% |
| Bipolar Disorder |
7.0% |
| Schizophrenia |
5.3% |
| Obsessive-compulsive Disorder |
3.8% |
| Schizophrenia, Paranoid Type |
3.8% |
| Dementia |
3.7% |
| Mania |
3.7% |
| Insomnia |
3.2% |
| Aggression |
2.9% |
| Hepatitis C |
2.9% |
| Epilepsy |
2.7% |
| Bipolar I Disorder |
2.2% |
| Hypertension |
2.1% |
| Haemorrhage |
1.9% |
| Anorexia Nervosa |
1.4% |
| Myocardial Infarction |
1.4% |
| Osteoporosis |
1.3% |
|
| Drug Interaction |
27.8% |
| White Blood Cell Count Decreased |
7.9% |
| Tremor |
7.1% |
| Neuroleptic Malignant Syndrome |
6.3% |
| Weight Increased |
6.3% |
| Mania |
5.6% |
| Rhabdomyolysis |
4.0% |
| Abnormal Weight Gain |
3.2% |
| Electrocardiogram Qt Prolonged |
3.2% |
| Sudden Death |
3.2% |
| Syncope |
3.2% |
| Toxic Encephalopathy |
3.2% |
| Hyperammonaemic Encephalopathy |
2.4% |
| Malaise |
2.4% |
| Muscle Disorder |
2.4% |
| Nausea |
2.4% |
| Neutrophil Count Decreased |
2.4% |
| Oedema Peripheral |
2.4% |
| Pancytopenia |
2.4% |
| Serotonin Syndrome |
2.4% |
|
